EL RIESGO DE TROMBOEMBOLISMO VENOSO EN MUJERES MEDICADAS CON ACETATO DE CIPROTERONA EN COMBINACION CON ETINILESTRADIOL: ANALISIS DE COHORTE Y ESTUDIO DE CASOS Y CONTROLES ANIDADOS
Columnista Experta de SIIC Helen Seaman
en colaboración con
Corinne de Vries MSc Pharm, PhD; , Department of Pharmacoepidemiology, Postgraduate Medical School, University of Surrey; Richard Farmer MB, PhD, FFPHM , Department of Pharmacoepidemiology, Postgraduate Medical School, University of Surrey
Primera edición en siicsalud:
13 de octubre, 2005
Sección Artículos originales,
subsección
Expertos de Iberoamérica,
página
/des/expertocompleto.php/71753
Especialidad principal:
Cardiología
Especialidades relacionadas:
Farmacología,Hematología,Medicina Farmacéutica,Medicina Interna,
Seaman HE, De Vries CS, Farmer RDT. Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette®): observational studies using the UK General Practice Research Database, Pharmacoepidemiology and Drug Safety 13(13):427-436, 2004
Seaman HE, De Vries CS, Farmer RDT. The risk of liver disorders in women prescribed cyproterone acetate in combination with ethinyloestradiol (Dianette): a nested case-control study using the GPRD, Pharmacoepidemiology and Drug Safety 12(12):541-550, 2003
Seaman HE, De Vries CS, Farmer RDT. The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl oestradiol: a nested cohort analysis & case-control study, Human Reproduction 18(18):522-526, 2003
Seaman HE, de Vries CS, Farmer RDT. Differences in the use of combined oral contraceptives amongst women with and without acne, Human Reproduction 18(18):515-521, 2003
Seaman HE, Lawrenson RA, Williams TJ, MacRae KD, Farmer RDT. The risk of liver damage associated with minocycline: a comparative study, Journal of Clinical Pharmacology 41(41):852-860, 2001
Lawrenson RA, Seaman HE, Sundström A, Williams TJ, Farmer RDT. Liver damage associated with minocycline use in acne: a systematic review of the published literature and pharmacovigilance data, Drug Safety 23(23):333-349, 2000
Helen Seaman
